𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study

✍ Scribed by John A. Thompson; Alexander Fefer


Publisher
Springer US
Year
1987
Tongue
English
Weight
286 KB
Volume
5
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

✦ Synopsis


This report expands on previous work with interferon alfa-2b (Intron A; Schering-Plough) in the treatment of hairy cell leukemia (HCL). Sixty-four patients were treated, with 89% achieving a response (either CR, PR or MR). The percentage of hairy cells in the peripheral blood decreased dramatically within one month and in the marrow, progressively over nine months. Normalization of blood counts was associated with a marked decline in serious infections and in the need for red cell or platelet transfusions. Preliminary results with a further group of patients confirm these satisfactory results.


πŸ“œ SIMILAR VOLUMES


Deoxycoformycin in the treatment of pati
✍ Montserrat Rafel; Francisco Cervantes; JosΓ© MarΓ­a BeltrΓ‘n; Francisco Zuazu; Luis πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 81 KB πŸ‘ 2 views

## Background: Deoxycoformycin (dcf) has been reported to produce high response rates in patients with hairy cell leukemia (hcl), but to the authors' knowledge data regarding experience with such therapy in a large hcl series are scarce. ## Methods: Between 1988-1997, dcf (4 mg/m(2)/day, every 2

Lymphoblastoid interferon alfa-n1 improv
✍ Geoffrey C. Farrell; Bruce R. Bacon; Robert D. Goldin πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 122 KB πŸ‘ 2 views

The aim of this study was to compare the short-term and long-term efficacy and safety of lymphoblastoid interferon with a recombinant interferon alfa (IFN-␣) in a 24-week treatment course for chronic hepatitis C. One thousand seventy-one patients with chronic hepatitis C were randomized to receive l